• OPEN AN ACCOUNT
Indian Indices
Sensex
77,632.46 866.54
( 1.13%)
Global Indices
Nasdaq
52,776.51 545.43
(1.04%)
Dow Jones
7,451.65 17.47
(0.23%)
Hang Seng
61,006.88 -1,358.04
(-2.18%)
Nikkei 225
10,879.18 97.43
(0.90%)
Forex
USD-INR
95.97 -0.70
(-0.72%)
EUR-INR
109.29 -0.89
(-0.81%)
GBP-INR
127.84 -1.20
(-0.93%)
JPY-INR
0.59 0.00
(-0.81%)

EQUITY - MARKET SCREENER

Goldiam International Ltd
Industry :  Diamond Cutting / Jewellery
BSE Code
ISIN Demat
Book Value()
526729
INE025B01025
35.9181652
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GOLDIAM
106.98
5379.41
EPS(TTM)
Face Value()
Div & Yield %
3.34
2
0
 

Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter
May 29,2026
Net profit of Fredun Pharmaceuticals rose 79.67% to Rs 10.78 crore in the quarter ended March 2026 as against Rs 6.00 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 65.25% to Rs 32.62 crore in the year ended March 2026 as against Rs 19.74 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales210.41165.44 27 633.33451.71 40
OPM %13.7310.43 -13.9212.16 -
PBDT14.409.10 58 55.2432.53 70
PBT11.257.26 55 47.0027.49 71
NP10.786.00 80 32.6219.74 65